{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:12:24Z","timestamp":1789398744356,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Natural Science Fund joint project of Shigatse Science and Technology Bureau","award":["RKZ2023ZR-017"],"award-info":[{"award-number":["RKZ2023ZR-017"]}]},{"DOI":"10.13039\/501100003399","name":"Shanghai Science and Technology Commission","doi-asserted-by":"crossref","award":["23015830500"],"award-info":[{"award-number":["23015830500"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>High-altitude pulmonary edema (HAPE) refers to the onset of breathlessness, cough, and fever at rest after arriving at high altitudes. It is a life-threatening illness caused by rapid ascent to high altitudes. Furosemide is controversial in HAPE treatment but is routinely used in China. Further research is needed to assess its efficacy and impact on HAPE management and prognosis. The aim of this study is to determine the effectiveness of furosemide for HAPE.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective was conducted to analysis of patients with HAPE admitted to the People\u2019s Hospital of Shigatse City from January 2018 to September 2023. Patients were divided into furosemide group and non-furosemide group for further analysis. Clinical variables including demographic information, comorbidities, vital signs, inflammatory markers, biochemical analysis, CT severity score and prognostic indicators were collected.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 273 patients were enrolled, with 209 patients in the furosemide group and 64 patients in the non-furosemide group. The furosemide group showed a significantly decrease in CT severity scores compared to the non-furosemide group. Subgroup analysis showed that the longer the duration of furosemide use, the more pronounced the improvement in lung CT severity scores. But there were no significant differences in length of hospital stay and in-hospital mortality between the two groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Furosemide helps alleviate pulmonary edema in HAPE patients, but further research is needed to clarify its impact on prognosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-024-02933-x","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T14:02:38Z","timestamp":1709560958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effect of furosemide in the treatment of high-altitude pulmonary edema"],"prefix":"10.1186","volume":"24","author":[{"given":"Dava","family":"Tenzing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pianduo","family":"Suolang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deji","family":"Gesang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duoji","family":"Suolang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaozhan","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangmu","family":"Ciren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongtian","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,4]]},"reference":[{"key":"2933_CR1","unstructured":"Clark ST, Sheraton MEMS, High-Altitude. Field Prophylaxis And Treatment. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Mack Sheraton declares no relevant financial relationships with ineligible companies.2023."},{"key":"2933_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.rmed.2018.11.004","volume":"145","author":"Y Li","year":"2018","unstructured":"Li Y, Zhang Y, Zhang Y. Research advances in pathogenesis and prophylactic measures of acute high altitude illness. Respir Med. 2018;145:145\u201352.","journal-title":"Respir Med"},{"issue":"9373","key":"2933_CR3","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/S0140-6736(03)13591-X","volume":"361","author":"B Basnyat","year":"2003","unstructured":"Basnyat B, Murdoch DR. High-altitude illness. Lancet. 2003;361(9373):1967\u201374.","journal-title":"Lancet"},{"issue":"4","key":"2933_CR4","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1056\/NEJMra2104829","volume":"386","author":"AM Luks","year":"2022","unstructured":"Luks AM, Hackett PH. Medical conditions and high-Altitude Travel. N Engl J Med. 2022;386(4):364\u201373.","journal-title":"N Engl J Med"},{"issue":"4","key":"2933_CR5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1580\/07-WEME-REV-173.1","volume":"19","author":"JO Stream","year":"2008","unstructured":"Stream JO, Grissom CK. Update on high-altitude pulmonary edema: pathogenesis, prevention, and treatment. Wilderness Environ Med. 2008;19(4):293\u2013303.","journal-title":"Wilderness Environ Med"},{"issue":"6","key":"2933_CR6","first-page":"CD009567","volume":"6","author":"D Simancas-Racines","year":"2018","unstructured":"Simancas-Racines D, Arevalo-Rodriguez I, Osorio D, Franco JV, Xu Y, Hidalgo R. Interventions for treating acute high altitude illness. Cochrane Database Syst Rev. 2018;6(6):CD009567.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2933_CR7","first-page":"127","volume":"30","author":"BH Zheng","year":"2007","unstructured":"Zheng BH, Li SZ, He Y, Wang HB, Li SS. [The effect of inhaled nitric oxide on endothelium-derived angiokinetic factors in patients with acute high altitude disease]. Zhonghua Jie He He Hu Xi Za Zhi. 2007;30(2):127\u20139.","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"issue":"4","key":"2933_CR8","first-page":"212","volume":"21","author":"W Wang","year":"1998","unstructured":"Wang W, Zhang X, Ma Y. [Low-concentration nitrous oxide inhalation in the treatment of high-altitude pulmonary edema]. Zhonghua Jie He He Hu Xi Za Zhi. 1998;21(4):212\u20134.","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"2933_CR9","first-page":"6697677","volume":"2021","author":"GA Saeed","year":"2021","unstructured":"Saeed GA, Gaba W, Shah A, Al Helali AA, Raidullah E, Al Ali AB, et al. Correlation between Chest CT Severity Scores and the clinical parameters of adult patients with COVID-19 pneumonia. Radiol Res Pract. 2021;2021:6697677.","journal-title":"Radiol Res Pract"},{"issue":"2","key":"2933_CR10","doi-asserted-by":"publisher","first-page":"e13461","DOI":"10.1111\/apha.13461","volume":"229","author":"M Gojkovic","year":"2020","unstructured":"Gojkovic M, Darmasaputra GS, Velica P, Rundqvist H, Johnson RS. Deregulated hypoxic response in myeloid cells: a model for high-altitude pulmonary oedema (HAPE). Acta Physiol (Oxf). 2020;229(2):e13461.","journal-title":"Acta Physiol (Oxf)"},{"issue":"6","key":"2933_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.amjms.2019.09.011","volume":"358","author":"L Dobbe","year":"2019","unstructured":"Dobbe L, Rahman R, Elmassry M, Paz P, Nugent K. Cardiogenic pulmonary edema. Am J Med Sci. 2019;358(6):389\u201397.","journal-title":"Am J Med Sci"},{"issue":"2","key":"2933_CR12","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1053\/j.ajkd.2021.09.029","volume":"80","author":"JE Novak","year":"2022","unstructured":"Novak JE, Ellison DH. Diuretics in States of volume overload: Core Curriculum 2022. Am J Kidney Dis. 2022;80(2):264\u201376.","journal-title":"Am J Kidney Dis"},{"key":"2933_CR13","doi-asserted-by":"publisher","first-page":"1007316","DOI":"10.3389\/fphys.2022.1007316","volume":"13","author":"K Tetzlaff","year":"2022","unstructured":"Tetzlaff K, Swenson ER, Bartsch P. An update on environment-induced pulmonary edema - when the lungs leak under water and in thin air. Front Physiol. 2022;13:1007316.","journal-title":"Front Physiol"},{"issue":"2","key":"2933_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1586\/ecp.10.136","volume":"4","author":"J John","year":"2011","unstructured":"John J, Palevsky H. Clinical pharmacology and efficacy of inhaled iloprost for the treatment of pulmonary arterial hypertension. Expert Rev Clin Pharmacol. 2011;4(2):197\u2013205.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"8","key":"2933_CR15","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1513\/AnnalsATS.202004-327CME","volume":"17","author":"AM Luks","year":"2020","unstructured":"Luks AM, Swenson ER. COVID-19 Lung Injury and High-Altitude Pulmonary Edema. A false equation with dangerous implications. Ann Am Thorac Soc. 2020;17(8):918\u201321.","journal-title":"Ann Am Thorac Soc"},{"issue":"6","key":"2933_CR16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/jama.1975.03260190017004","volume":"234","author":"HN Hultgren","year":"1975","unstructured":"Hultgren HN, Letter. Furosemide for high altitude pulmonary edema. JAMA. 1975;234(6):589\u201390.","journal-title":"JAMA"},{"issue":"10203","key":"2933_CR17","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S0140-6736(19)31282-6","volume":"394","author":"T Easterling","year":"2019","unstructured":"Easterling T, Mundle S, Bracken H, Parvekar S, Mool S, Magee LA, et al. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial. Lancet. 2019;394(10203):1011\u201321.","journal-title":"Lancet"},{"key":"2933_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.resp.2014.09.023","volume":"209","author":"K Korzeniewski","year":"2015","unstructured":"Korzeniewski K, Nitsch-Osuch A, Guzek A, Juszczak D. High altitude pulmonary edema in mountain climbers. Respir Physiol Neurobiol. 2015;209:33\u20138.","journal-title":"Respir Physiol Neurobiol"},{"issue":"24","key":"2933_CR19","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMcp1214870","volume":"368","author":"P Bartsch","year":"2013","unstructured":"Bartsch P, Swenson ER. Clinical practice: Acute high-altitude illnesses. N Engl J Med. 2013;368(24):2294\u2013302.","journal-title":"N Engl J Med"},{"issue":"4","key":"2933_CR20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/jtm.12017","volume":"20","author":"N Netzer","year":"2013","unstructured":"Netzer N, Strohl K, Faulhaber M, Gatterer H, Burtscher M. Hypoxia-related altitude illnesses. J Travel Med. 2013;20(4):247\u201355.","journal-title":"J Travel Med"},{"issue":"1","key":"2933_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.wem.2020.10.003","volume":"32","author":"MCJ Dekker","year":"2021","unstructured":"Dekker MCJ, Mremi A, Kilonzo KG, Nyakunga G, Sakita F, Mvungi M, et al. Altitude-Related disorders on Mount Kilimanjaro, Tanzania: two-year survey in a local Referral Center. Wilderness Environ Med. 2021;32(1):36\u201340.","journal-title":"Wilderness Environ Med"},{"issue":"4","key":"2933_CR22","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1089\/ham.2022.0083","volume":"23","author":"RR Berendsen","year":"2022","unstructured":"Berendsen RR, Bartsch P, Basnyat B, Berger MM, Hackett P, Luks AM, et al. Strengthening Altitude Knowledge: a Delphi Study to define Minimum Knowledge of Altitude Illness for laypersons traveling to high Altitude. High Alt Med Biol. 2022;23(4):330\u20137.","journal-title":"High Alt Med Biol"},{"issue":"1 Suppl","key":"2933_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/00005768-199901001-00004","volume":"31","author":"P Bartsch","year":"1999","unstructured":"Bartsch P. High altitude pulmonary edema. Med Sci Sports Exerc. 1999;31(1 Suppl):23\u20137.","journal-title":"Med Sci Sports Exerc"},{"issue":"1","key":"2933_CR24","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.wem.2018.11.002","volume":"30","author":"A Bhattarai","year":"2019","unstructured":"Bhattarai A, Acharya S, Yadav JK, Wilkes M. Delayed-Onset High Altitude Pulmonary Edema: a Case Report. Wilderness Environ Med. 2019;30(1):90\u20132.","journal-title":"Wilderness Environ Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-02933-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-024-02933-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-02933-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T20:05:19Z","timestamp":1709928319000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-024-02933-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,4]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2933"],"URL":"https:\/\/doi.org\/10.1186\/s12890-024-02933-x","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,4]]},"assertion":[{"value":"15 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the People\u2019s Hospital of Shigatse City, and written informed consent was obtained from each patient or their family members.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}